128 related articles for article (PubMed ID: 29303105)
1. Turkey 2017 Clinical Practice Guidelines on recommendations for screening diagnosing and managing hepatitis C virus.
Idilman R; Baykam N; Kaymakoğlu S; Tabak F; Bahçecioğlu HI; Bektaş A; Bulut C; Günşar F; İnan D; Karaosmanoğlu HK; Karasu Z; Kuşçu F; Mete B; Özbakır Ö; Özdoğan OC; Parlak M; Sırmatel F; Topalak Ö; Ünsal B; Guidelines Study Group VH
Turk J Gastroenterol; 2017 Dec; 28(Suppl 2):90-93. PubMed ID: 29303105
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines.
Tabak F; Yurdaydın C; Kaymakoğlu S; Akarsu M; Akıncı EG; Akkız H; Alkım C; Çekin AH; Çuvalcı NÖ; Demir K; Değertekin B; Dökmetaş İ; Ersöz G; Hizel K; Kandemir FÖ; Önlen Y; Sonsuz A; Şenateş E; Tosun S; Tözün N; Idilman R; Guidelines Study Group VH
Turk J Gastroenterol; 2017 Dec; 28(Suppl 2):73-83. PubMed ID: 29303103
[No Abstract] [Full Text] [Related]
3. Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines.
Yurdaydın C; Tabak F; Kaymakoğlu S; Akarsu M; Akıncı EG; Akkız H; Alkım C; Çekin AH; Çuvalcı NÖ; Demir K; Değertekin B; Dökmetaş İ; Ersöz G; Hizel K; Kandemir FÖ; Önlen Y; Sonsuz A; Şenateş E; Tosun S; Tözün N; Idilman R; Guidelines Study Group VH
Turk J Gastroenterol; 2017 Dec; 28(Suppl 2):84-89. PubMed ID: 29303104
[No Abstract] [Full Text] [Related]
4. Management of end-stage liver disease in HIV/hepatitis C virus co-infection.
Spengler U
Curr Opin HIV AIDS; 2011 Nov; 6(6):527-33. PubMed ID: 21918437
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.
Deming P; Martin MT; Chan J; Dilworth TJ; El-Lababidi R; Love BL; Mohammad RA; Nguyen A; Spooner LM; Wortman SB
Pharmacotherapy; 2016 Feb; 36(2):203-17. PubMed ID: 26846728
[TBL] [Abstract][Full Text] [Related]
6. From current status to optimization of HCV treatment: Recommendations from an expert panel.
Craxì A; Perno CF; Viganò M; Ceccherini-Silberstein F; Petta S;
Dig Liver Dis; 2016 Sep; 48(9):995-1005. PubMed ID: 27388261
[TBL] [Abstract][Full Text] [Related]
7. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
8. Management of hepatitis C positive patients undergoing active treatment for malignancies: A position paper from the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Malattie Infettive e Tropicali (SIMIT).
Bruno R; Zuccaro V; Pinto C; Puoti M; Gaeta GB; Pagani A; Taliani G; Baldanti F; Cinieri S; Pedrazzoli P
Semin Oncol; 2018 Oct; 45(5-6):259-263. PubMed ID: 30482634
[TBL] [Abstract][Full Text] [Related]
9. Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group.
Andreone P; Di Marco V; Gaeta GB; Fagiuoli S; Vukotic R; Craxì A
Dig Liver Dis; 2019 Jul; 51(7):915-921. PubMed ID: 31031174
[TBL] [Abstract][Full Text] [Related]
10. Consensus guidelines for the management of hepatitis C infection.
Consensus Guidelines Committee for the Management of Hepatitis C Infection
Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
[TBL] [Abstract][Full Text] [Related]
11. Can family physicians have a role in eradication of hepatitis c infection?
Şahin AR; Erdoğan A; Gisi K; İspiroğlu M; Ateş S; Okyay RA; Nazik S; Kantarçeken B
Turk J Gastroenterol; 2020 May; 31(5):393-399. PubMed ID: 32519959
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
AASLD-IDSA HCV Guidance Panel
Clin Infect Dis; 2018 Oct; 67(10):1477-1492. PubMed ID: 30215672
[TBL] [Abstract][Full Text] [Related]
13. Recommendation for treatment of hepatitis C virus infection.
Kaymakoğlu S; Köksal İ; Tabak F; Akarca US; Akbulut A; Akyüz F; Bodur H; Çağatay A; Dinçer D; Esen Ş; Güner R; Gürel S; Köse Ş; Şentürk Ö; Şimşek H; Yamazhan T; Yılmaz Y; Idilman R; Guidelines Study Group VH
Turk J Gastroenterol; 2017 Dec; 28(Suppl 2):94-100. PubMed ID: 29303106
[No Abstract] [Full Text] [Related]
14. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
U.S. Public Health Service
MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
[TBL] [Abstract][Full Text] [Related]
15. 2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.
European Association of the Study of the Liver
Liver Int; 2012 Feb; 32 Suppl 1():2-8. PubMed ID: 22212565
[TBL] [Abstract][Full Text] [Related]
16. [Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 2 and 3].
Jung YK
Korean J Gastroenterol; 2016 Mar; 67(3):132-6. PubMed ID: 26996182
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
19. Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.
; ;
Dig Liver Dis; 2010 Feb; 42(2):81-91. PubMed ID: 19748329
[TBL] [Abstract][Full Text] [Related]
20. Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.
Torres HA; Mahale P
Liver Int; 2015 Jun; 35(6):1661-4. PubMed ID: 25779000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
